Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
09/2012
09/27/2012WO2012127030A1 Arylpiperazines as neuroprotective agents
09/27/2012US20120245352 Quinoxaline Compounds and Derivatives
09/26/2012CN1791395B 免疫抑制剂化合物及组合物 Immunosuppressive compounds and compositions
09/26/2012CN102690646A Electrochromism material and electrochromism device
09/26/2012CN102690244A Substances regulating alpha-synuclein accumulation and its pharmaceutical application
09/26/2012CN101829602B Catalytic system for preparing N-Boc-aromatic amine compounds and preparation method and application thereof
09/26/2012CN101817791B Method for directly producing water soluble aniline black
09/26/2012CN101808992B 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
09/26/2012CN101724099B Aromatic ketone compound and photoinitiator with same
09/25/2012USRE43688 Compositions and methods related to serotonin 5-HT1A receptors
09/25/2012US8273884 Methods of making cyclic, N-amino functional triamines
09/25/2012US8273883 Method for producing optically active 2-arylpiperazine derivative
09/25/2012US8273882 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
09/25/2012US8273881 Phenazine compounds and use thereof in autoimmune and inflammatory diseases
09/25/2012US8273767 Bicyclic-substituted amines as histamine-3 receptor ligands
09/25/2012US8273749 N-substituted oxindoline derivatives as calcium channel blockers
09/25/2012CA2560071C Lysine based compounds
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012122805A1 Medicine for treating ischemic brain injury and its sequelae and preparation method thereof
09/20/2012WO2012122605A1 Iridium based complex for water splitting
09/20/2012US20120238747 Transfection reagents
09/20/2012US20120238581 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
09/20/2012US20120238578 Compositions useful as inhibitors of voltage-gated sodium channels
09/20/2012CA2830157A1 Guanidine compound
09/19/2012CN102686563A Substituted benzamide derivatives
09/19/2012CN102675401A Preparation of anti-tumor medicine LQC-Y and application thereof
09/19/2012CN102675233A New high-yield production process of 6-chloro-2-hydroxyquinoxaline
09/19/2012CN102675232A Synthetic method of 4-(6-chlorine-quinoxaline-2-yloxy)-phenol
09/19/2012CN102675231A Method for removing sulfur content impurity in synthesis technology of 2, 6-dichloro-quinoxaline
09/19/2012CN102675230A Preparation method of 3-amino-2-cyanogroup-6-bromide pyrazine
09/19/2012CN102675229A Preparation method for 2,5-dimethylpyrazine derivative
09/19/2012CN102675228A Medicine for treating ischemic brain injury stroke and sequela of ischemic brain injury stroke and preparation method for medicine
09/19/2012CN102675227A Preparation method of high-purity dexrazoxane
09/18/2012US8269045 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof
09/18/2012US8269004 Heterocyclical anti-aromatic chromophore architectures
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012CA2546002C 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
09/13/2012WO2012120398A1 Aryl substituted carboxamide derivatives as trpm8 modulators
09/13/2012WO2012119458A1 Synthesis and use of antitumor drug lqc-y
09/13/2012US20120232272 PROCESS FOR PRODUCING v-COELENTERAZINE COMPOUNDS
09/13/2012US20120232194 Phthalocyanine compound and production method therefor, and coloring composition containing the phthalocyanine compound
09/13/2012US20120232079 Novel acylpiperazinones and their use as pharmaceuticals
09/13/2012US20120227802 Organic compound and photovoltaic device comprising the same
09/13/2012US20120227545 Aqueous leaching process for recovery of precious metals with addition of di-thiooxamide ligand
09/12/2012CN102665452A Extracts and beverages containing 2, 5-piperazinedione, 3, 6-bis (phenylmethyl) -, (3s, 6s) -
09/12/2012CN102665451A Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3s,6s)-
09/12/2012CN102659694A Method for synthesizing quizalofop-p-ethyl intermediate 6-chlorin-2-(4-p-hydroxyl radical) quinoxaline by one pot method
09/12/2012CN102659693A 3-methylquinoxaline-2-carboxylic acid artificial antigen and antibody obtained by the 3-methylquinoxaline-2-carboxylic acid artificial antigen
09/12/2012CN101941941B Carboxylic ester compound and applications thereof
09/12/2012CN101817823B Preparation method of 4,7-diazaindole and 5-site substitute thereof
09/11/2012US8263768 Process for the stereoselective preparation of bicyclic heterocycles
09/11/2012US8263657 Blocking neurokinins; using a benzene compound containing hydroxy or acetoxy group; antiinflammatory agents
09/11/2012US8263634 Heteroaryl-ureas and their use as glucokinase activators
09/11/2012US8263578 Stable bortezomib formulations
09/07/2012WO2012118492A1 Heterocyclic sulfonamides as raf inhibitors
09/07/2012WO2012087889A3 Dna methylation inhibitors
09/06/2012US20120225891 Amide derivatives, process for preparation thereof and use thereof as insecticide
09/06/2012US20120225890 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
09/06/2012US20120225863 Heterocyclic compounds for the inhibition of pask
09/06/2012US20120225862 Heteroaryl benzamides, compositions and methods of use
09/06/2012US20120225846 Heterocyclic compounds for the inhibition of pask
09/05/2012CN102656151A Substituted heterocyclic derivatives for the treatment of pain and epilepsy
09/05/2012CN102656149A Benzamide compound
09/05/2012CN101918363B Phenyl acetamide derivative
09/05/2012CN101863845B Preparation method of 5-methylpyrazine-2-carboxylic acid
09/05/2012CN101111475B Antiviral compounds and methods
09/04/2012US8258345 Hydroxylation of β-dicarbonyls with zirconium catalysts
09/04/2012US8258139 Method of treatment for mental disorders
09/04/2012US8258135 Quinolizidinone M1 receptor positive allosteric modulators
08/2012
08/30/2012WO2012115608A2 Polyamine inhibitors for the treatment and prevention of parkinson's disease
08/30/2012WO2012114268A1 Benzamide derivatives as p2x7 receptor antagonists
08/30/2012US20120220751 Non-Fluorescent Quencher Compounds and Biomolecular Assays
08/30/2012US20120220606 New capped pyrazinoylguanidine sodium channel blockers
08/30/2012US20120220605 Oxopiperazine derivatives for the treatment of pain and epilepsy
08/30/2012US20120220603 Substituted heterocyclic derivatives for the treatment of pain and epilepsy
08/30/2012US20120220601 Delta opioid receptor agonist compounds
08/30/2012US20120220596 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
08/30/2012CA2824415A1 Benzamide derivatives as p2x7 receptor antagonists
08/29/2012EP2493269A1 Organometallic compounds and emmission-shifting organic electrophosphorence
08/29/2012EP2491030A1 Fused ring analogues of anti-fibrotic agents
08/29/2012EP2491022A1 Diazepam derivatives as modulators of chemokine receptors
08/29/2012EP2491021A1 Novel acylpiperazinones and their use as pharmaceuticals
08/29/2012CN102649779A Synthesis method for medicine intermediate 1-methyl-3-phenylpiperazine
08/29/2012CN102002006B Method for preparing 2,3-dimethyl pyrazine
08/29/2012CN101874798B Difunctional inhibitor of leukotriene A4 hydrolase and cyclooxygenase and application thereof
08/29/2012CN101155789B 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252796 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof
08/28/2012CA2656079C Cyclic amine compound
08/23/2012WO2012111579A1 Light-emitting element
08/23/2012WO2012110833A2 Fluorescence modulators
08/23/2012US20120214822 N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo- 1 (2h)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses
08/23/2012US20120214800 Organic Compounds
08/23/2012US20120214785 New compounds, pharmaceutical compositions and uses thereof
08/23/2012US20120214735 Acetamide derivatives as glucokinase activators, their process and medicinal applications
08/22/2012EP2489350A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
08/22/2012EP1963346B1 Organometallic complex and light-emitting element, light-emitting device and electronic device using the same
08/22/2012CN102648180A Modulators of G protein-coupled receptor 88
08/22/2012CN102643240A Heterocyclic compound
08/22/2012CN102643239A Synthetic method of 2,5-diphenyl pyrazine
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 187